First Republic Investment Management, Inc. Rocket Pharmaceuticals, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$16.59 - $23.6 $23,408 - $33,299	1,411 Added 4.02%	36,530 $725,000
Q1 2023 May 11, 2023	SELL	$15.79 - $22.6 $25,564 - $36,589	-1,619 Reduced 4.41%	35,119 $601,000
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $569,439 - $836,156	36,738 New	36,738 $718,000

Others Institutions Holding RCKT

# of Institutions

218

Shares Held

93.3M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$183 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$116 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$64 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$57.3 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$46.5 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $783M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account